Not applicableUnknownNCT02035891What this trial is testingLow-dose Colchicine in Patients With Type 2 Diabetes Mellitus and MicroalbuminuriaWho this might be right forDiabetic Nephropathy Chongqing Medical University 160
Large-scale testing (Phase 3)Ended earlyNCT04741074What this trial is testingEffect of Subcutaneous Semaglutide on Kidney Transplant CandidacyWho this might be right forCKDDiabetic Kidney DiseaseType 2 Diabetes Mellitus in Obese+2 more Geisinger Clinic 15
Testing effectiveness (Phase 2)Study completedNCT01667614What this trial is testingEffects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood PressureWho this might be right forType 2 Diabetes MellitusDiabetic NephropathyEssential Hypertension Tehran University of Medical Sciences 136
Not applicableStudy completedNCT02276742What this trial is testingLifestyle Management of CKD in Obese Diabetic PatientsWho this might be right forObesityType 2 DiabetesChronic Kidney Disease (CKD) NYU Langone Health 269
Testing effectiveness (Phase 2)Ended earlyNCT04983979What this trial is testingThe ORTIZ Study: Optimising RASi Therapy With SZCWho this might be right forCKDDiabetes Mellitus, Type 2Hyperkalemia Barts & The London NHS Trust 18
Large-scale testing (Phase 3)Ended earlyNCT00120328What this trial is testingTo Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic NephropathyWho this might be right forDiabetic Nephropathy Speedel Pharma Ltd. 2,364
Testing effectiveness (Phase 2)Study completedNCT02177786What this trial is testingEfficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney DiseaseWho this might be right forDiabetic Kidney Disease Gilead Sciences 334
Not applicableStudy completedNCT00364988What this trial is testingPioglitazone and Losartan Provides Additional RenoprotectionWho this might be right forType 2 DiabetesDiabetic Nephropathy Shanghai Jiao Tong University School of Medicine 60
Testing effectiveness (Phase 2)Study completedNCT05718375What this trial is testingPhase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With AlbuminuriaWho this might be right forDiabetic Nephropathies Curacle Co., Ltd. 240
Large-scale testing (Phase 3)Study completedNCT02251431What this trial is testingExtended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal SyndromeWho this might be right forType 2 Diabetes MellitusChronic Kidney DiseaseLeft Ventricular Diastolic Dysfunction Baylor Research Institute 57
Post-approval studies (Phase 4)Study completedNCT02009514What this trial is testingGlucose Containing and Glucose Free Hemodialysate in Type 2 Diabetic PatientsWho this might be right forEnd-Stage Kidney DiseaseType 2 Diabetes Mellitus Tampere University Hospital 10
Post-approval studies (Phase 4)Study completedNCT02911792What this trial is testingEffect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With HyperfiltrationWho this might be right forDiabetes Mellitus, Type 2 The University of Texas Health Science Center at San Antonio 72
Not applicableStudy completedNCT05577650What this trial is testingPrevalence of Chronic Kidney Disease in Tunisian DiabeticsWho this might be right forChronic Kidney DiseasesDiabetes MellitusDiabetes Type 2 Dacima Consulting 10,145
Testing effectiveness (Phase 2)Study completedNCT01356849What this trial is testingEvaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) InhibitorWho this might be right forChronic Kidney DiseaseDiabetic Nephropathy AbbVie (prior sponsor, Abbott) 149
Large-scale testing (Phase 3)UnknownNCT04531163What this trial is testingPossible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced NephropathyWho this might be right forDiabetic Kidney DiseaseDiabetes Mellitus, Type 2Diabetic Nephropathies Al-Azhar University 60
Large-scale testing (Phase 3)Study completedNCT00362960What this trial is testingOlmesartan Medoxomil and Diabetic NephropathyWho this might be right forType 2 Diabetes MellitusDiabetic NephropathyProteinuria+1 more Sankyo Pharma Gmbh 300
Testing effectiveness (Phase 2)Study completedNCT00097955What this trial is testingSafety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and ProteinuriaWho this might be right forDiabetic Nephropathy Novartis Pharmaceuticals 496
Large-scale testing (Phase 3)UnknownNCT05373004What this trial is testingComparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney DiseaseWho this might be right forDiabetic Nephropathy Type 2 Omar Tarek Elfarargi 212
Not applicableUnknownNCT03284996What this trial is testingDoppler Ultrasound in Early Detection of Diabetic Nephropathy Type 2 Diabetes Mellitus.Who this might be right forDiabetic Nephropathies Assiut University 80
Testing effectiveness (Phase 2)Study completedNCT03217591What this trial is testingEvaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by AlbuminuriaWho this might be right forType 2 Diabetes Mellitus With Diabetic Nephropathy Akebia Therapeutics 156